Episode Details

Back to Episodes
Episode 291: ASCO GU 2024: CONTACT2 - Cabozantinib and Atezolizumab in Prostate Cancer

Episode 291: ASCO GU 2024: CONTACT2 - Cabozantinib and Atezolizumab in Prostate Cancer

Season 2 Episode 291 Published 2 years, 9 months ago
Description
Neeraj Agarwal describes the results of this positive randomised Phase 3 trial.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us